NMPA Approval

Mitoxantrone Hydrochloride Liposome Injection

Approval Number

国药准字H20220001

Company石药集团中诺药业（石家庄）有限公司合并

Registration Date

January 7, 2022

Drug Information

Generic Name

盐酸米托蒽醌脂质体注射液

Dosage Form

注射剂

Strength

10ml:10mg（按C22H28N4O6计）

Drug Type

化学药品

Registration Date

January 7, 2022

Company Information

Applicant Company

Company Name石药集团中诺药业（石家庄）有限公司合并

Company Address

河北省石家庄经济技术开发区扬子路88号

Manufacturing Company

Company Name石药集团中诺药业（石家庄）有限公司合并

Company Address

石家庄市高新区秦岭大街111号；石家庄经济技术开发区扬子路57号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸米托蒽醌脂质体注射液 - NMPA 批准文号 | MedPath